Patient Reported Outcomes Registry in Patient With Cancer Cachexia (PROXie)

iOMEDICO

Status: Completed

Conditions: Metastatic Pancreatic Cancer; NSCLC, Metastatic

Study type: Observational

Funder types: Industry

Identifiers

NCT02983500

IOM-0050346

Details and patient eligibility

About

Evaluation of patient reported outcomes (PRO) with tumor cachexia in a real life setting.

Full description

The PRO Xie project will recruit a representative cohort of patients with advanced lung or advanced pancreatic cancer with a high risk for the development of cancer cachexia.

Patient Reported Outcomes (PRO) are assessed in a real life setting by a questionnaire consisting of 20 questions: QoL is measured by SF12, fatigue by FACIT-F and cachexia by FAACT questionnaires, respectively.

These data will determine the potential need for anti-cachexia treatment in those patients, as well as the number of underweight patients, the evaluation of general QoL, fatigue and cachexia and the evaluation of malnutrition.

Enrollment: 253 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Documented diagnosis of NSCLC UICC stage IIIB/IV or pancreatic cancer UICC stage III/IV
• Start of the first line palliative systemic treatment
• Ability to read and understand German
• Written informed consent

Exclusion criteria

• None